Sanigen Co., Ltd. (188260)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
2,005. 00
+21
+1.0585%
₩
15.97B Market Cap
- P/E Ratio
- Div Yield
3,708 Volume
- Eps
₩ 1,984
Previous Close Want to track 188260 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
188260 closed today higher at ₩2,005, an increase of 1.0585% from yesterday's close, completing a monthly increase of 3.886% or ₩75. Over the past 12 months, 188260 stock gained 4.2642%.
188260 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
Sanigen Co., Ltd. (188260) FAQ
What is the stock price today?
The current price is ₩2,005.00.
On which exchange is it traded?
Sanigen Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 188260.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 15.97B.
Has Sanigen Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Sanigen Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Sanigen Co., Ltd. is a specialized biotechnology company known for its innovative solutions in the fields of molecular diagnostics and advanced genetic research. With a particular focus on the development of diagnostic kits and services, Sanigen aims to enhance the early detection and management of diseases through cutting-edge technologies. The company leverages its extensive expertise in next-generation sequencing and bioinformatics to offer comprehensive genomic profiling, which is crucial for personalized medicine and research. Sanigen's products and services serve various sectors, including healthcare, pharmaceuticals, and academic research, providing tools that aid in understanding genetic factors and disease mechanisms. As a key player in the biotechnology industry, Sanigen Co., Ltd. contributes significantly to advancements in medical diagnostics and personalized treatment strategies, positioning itself as a pivotal entity in the evolving landscape of healthcare and genetic research.
Contact Information
Address: Pyeongchon Digital Empire Building 411
Phone: 82 1 833 8010
Website: https://www.sanigen.kr
